Atlas Trials

WEI XU

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch WEI XU

RecordFirmDate
R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma (NCT07764601)WEI XU2026-08-01
Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma (NCT07385989)WEI XU2026-01-25
Penpulimab in Maintenance Therapy in Lymphoma (NCT05680038)WEI XU2023-03-01
Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor (NCT05173467)Wei Xu2021-12-25
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary (NCT05241132)Wei Xu2021-11-12
Characteristics of Gut Microbiota in Patients With Colon Cancer of Different Traditional Chinese Medicine Syndromes (NCT03892252)Wei Xu2019-03-10

Track WEI XU automatically

Every clearance here is in the API, with alerts when new ones post.